Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study - PubMed

Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study - PubMed

Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study

Jennifer Foglietta 1, Vienna Ludovini 2, Fortunato Bianconi 3, Lorenza Pistola 2, Maria Sole Reda 2, Antonella Al-Refaie 2, Francesca Romana Tofanetti 2, Annamaria Mosconi 2, Elisa Minenza 2, Paola Anastasi 2, Carmen Molica 2, Fabrizio Stracci 4, Fausto Roila 2

Affiliations 

• PMID: 32806537
 
• DOI: 10.3390/genes11080925

Free article

Abstract

Hereditary breast and ovarian cancers are mainly linked to variants in BRCA1/2 genes. Recently, data has shown that identification of BRCA variants has an immediate impact not only in cancer prevention but also in targeted therapeutic approaches. This prospective observational study characterized the overall germline BRCA variant and variant of uncertain significance (VUS) frequency and spectrum in individuals affected by breast (BC) or ovarian cancer (OC) and in healthy individuals at risk by sequencing the entire BRCA genes. Of the 363 probands analyzed, 50 (13.8%) were BRCA1/2 mutated, 28 (7.7%) at BRCA1 and 23 (6.3%) at BRCA2 gene. The variant c.5266dupC p.(Gln1756Profs) was the most frequent alteration, representing 21.4% of the BRCA1 variants and 12.0% of all variants identified. The variant c.6313delA p.(Ile2105Tyrfs) of BRCA2 was the most frequent alteration observed in 6 patients. Interestingly, two new variants were identified in BRCA2. In addition, 25 different VUS were identified; two were reported for the first time in BRCA1 and two in BRCA2. The number of triple-negative BCs was significantly higher in patients with the pathogenic BRCA1/2-variant (36.4%) than in BRCA1/2 VUS (16.0%) and BRCA1/2 wild-type patients (10.7%) (p < 0.001). Our study reveals that the overall frequency of BRCA germline variants in the selected high-risk Italian population is about 13.8%. We believe that our results could have significant implications for preventive strategies for unaffected BRCA-carriers and effective targeted treatments such as PARP inhibitors for patients with BC or OC.

Keywords: BRCA1/2 variant carrier; VUS; breast cancer; genetic testing; risk evaluation.

Similar articles

• Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.

  Cotrim DP, Ribeiro ARG, Paixão D, de Queiroz Soares DC, Jbili R, Pandolfi NC, Cezana C, de Cássia Mauro C, Mantoan H, Bovolim G, de Brot L, Torrezan GT, Carraro DM, Baiocchi G, da Cruz Formiga MN, da Costa AABA.BMC Cancer. 2019 Jan 3;19(1):4. doi: 10.1186/s12885-018-5235-3.PMID: 30606148 Free PMC article.
• Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.

  Kim YC, Zhao L, Zhang H, Huang Y, Cui J, Xiao F, Downs B, Wang SM.Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144.PMID: 26848529 Free PMC article.
• BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.

  Li A, Xie R, Zhi Q, Deng Y, Wu Y, Li W, Yang L, Jiao Z, Luo J, Zi Y, Sun G, Zhang J, Shi Y, Liu J.Gynecol Oncol. 2018 Oct;151(1):145-152. doi: 10.1016/j.ygyno.2018.07.024. Epub 2018 Aug 2.PMID: 30078507
• Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation.

  Golubeva VA, Nepomuceno TC, Monteiro ANA.Cancers (Basel). 2019 Apr 12;11(4):522. doi: 10.3390/cancers11040522.PMID: 31013702 Free PMC article. Review.
• BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer.

  Petrucelli N, Daly MB, Pal T.1998 Sep 4 [updated 2016 Dec 15]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 20301425 Free Books & Documents. Review.